Clinical Trials Directory

Trials / Unknown

UnknownNCT02608762

Neurobehavioral Outcomes and Quality of Life in Pediatric Patients With Brain or Head/Neck Tumors Receiving Proton or Photon Radiotherapy

Status
Unknown
Phase
Study type
Observational
Enrollment
72 (estimated)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

Background: Neurobehavioral functions and quality of life (QoL) are the important outcome measurements after radiotherapy in patients with brain tumors and even head/neck cancers. However, few studies have focused on neurobehavioral functions and QoL after anti-cancer treatment particularly brain radiotherapy for pediatric/adolescent patients with brain tumors. This study thus aims to prospectively evaluate those functions in pediatric or adolescent patients with brain or head/neck tumors in order to provide useful information about their clinical outcomes. Methods: A total of 72 pediatric/adolescent patients, who are diagnosed with brain tumors or head/neck cancers, were prospectively recruited. Neurobehavioral functions will be evaluated using a neuropsychological battery, which includes general cognitive functions, intelligence, memory, executive functions, information processing and emotional/behavioral expressions. The QoL will be evaluated by the health-related QoL questionnaire. All participants will be examined at six phases, which include pre-treatment, 1-month post-treatment, 4-month post-treatment, 1-year post-treatment, 2-year post-treatment and 3-year post-treatment. Expected results: Patients'neurobehavioral functions and QoL will show significant improvement after treatment, and the improvement will not be diminished across each post-treatment phase.

Conditions

Interventions

TypeNameDescription
RADIATIONstandard adjuvant local radiation therapy or cranial radiation therapy

Timeline

Start date
2013-09-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2015-11-20
Last updated
2023-05-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02608762. Inclusion in this directory is not an endorsement.